Sanofi Consumer Healthcare India Limited (NSEI: SANOFICONR)
Health Care · Pharmaceuticals · IN
Rs4,444.90
-1.54% today · -15.8% 1Y
Sanofi Consumer Healthcare India Limited (NSEI: SANOFICONR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.07B and employs 597 people.
Over the last twelve months the share price has lost 15.8%, trading between 3.98K and 5.36K.
Tweenvest scores Sanofi Consumer Healthcare India Limited across four factors: quality 71/100, value 66/100, dividend 29/100. Its strongest factor is quality.
SANOFICONR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.07B
- Revenue (TTM)
- $100.45M
- P/E
- 38.49
- EPS
- 115.49
- Dividend yield
- 1.69%
- Beta (5Y)
- —
- 52-week high
- Rs5,357.00
- 52-week low
- Rs3,975.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.03M
- Employees
- 597
- Next earnings
- —
About Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited, an Indian company founded in 2023 and based in Mumbai, specializes in fast-moving consumer healthcare products. The firm's offerings cover categories such as allergy relief, overall well-being, and pain management, featuring prominent brands like Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU. These products are distributed through a comprehensive network that includes distributors, wholesalers, government institutions, hospitals, pharmacies, pharmacy chains, and e-commerce platforms. The company operates as a subsidiary of Opella Healthcare Participations B.V.
- ISIN
- INE0UOS01011
- Founded
- 2023
- Listed since
- Sep 13, 2024
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.